FDA wants women to be warned of breast implant risks

The Food and Drug Administration is recommending manufacturers put a warning label on their breast implant devices so women are more aware of the risks of serious complications.

The big picture: Thousands of women who received implants have reported severe muscle and joint pain, weakness, cognitive difficulties and fatigue, the New York Times reports. This and a few recalls sparked a movement across the country to pressure the FDA in considering more long-term safety studies on connections between implants and disease.